- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06777823
Rejection Sensitivity and Puberty in Mental Health Vulnerability to Social Media Experiences in Early Adolescent Girls
April 30, 2026 updated by: Washington University School of Medicine
This longitudinal study is designed to test bidirectional relationships between preteen girls' mental health and social media experiences.
We will explore how pubertal development and experiences of rejection influence these relationships.
Study Overview
Status
Recruiting
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Estimated)
250
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Hailey Hatch, PhD
- Phone Number: 314-273-7288
- Email: hatchh@wustl.edu
Study Locations
-
-
Missouri
-
St Louis, Missouri, United States, 63110
- Recruiting
- Washington University School of Medicine
-
Contact:
- Hailey
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Child
- Adult
- Older Adult
Accepts Healthy Volunteers
Yes
Description
Inclusion Criteria:
- female aged 10-11 years
- engagement in social media use
- proficient in the English language
- family/personal device that can complete daily diaries
Exclusion Criteria:
- previously diagnosed chronic medical illness
- autism spectrum disorder
- significant developmental or speech delay
- endocrine disorder
- not assigned female at birth (AFAB)
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Basic Science
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: All participants
All participants complete the study intervention
|
All participants will receive this
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Psychopathology symptoms parent report
Time Frame: "Through study completion, an average of two years"
|
Measured via the KSADS interview
|
"Through study completion, an average of two years"
|
|
Psychopathology symptoms child report
Time Frame: "Through study completion, an average of two years"
|
Measured via the KSADS interview
|
"Through study completion, an average of two years"
|
|
Daily Diary Social Media experiences
Time Frame: Through study completion, an average of two years
|
Assessed through daily diary reports (e.g., 'Did you use social media today?")
|
Through study completion, an average of two years
|
|
MicroEMA Social Media experiences
Time Frame: Through study completion, an average of two years
|
Assessed through microEMA prompt (e.g., 'using Social Media?")
|
Through study completion, an average of two years
|
|
Social Media experiences child report
Time Frame: Through study completion, an average of two years
|
Assessed through a screen time questionnaire
|
Through study completion, an average of two years
|
|
Social Media experiences parent report
Time Frame: Through study completion, an average of two years
|
Assessed through a screen time questionnaire
|
Through study completion, an average of two years
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
February 5, 2025
Primary Completion (Estimated)
June 1, 2028
Study Completion (Estimated)
June 30, 2029
Study Registration Dates
First Submitted
December 30, 2024
First Submitted That Met QC Criteria
January 10, 2025
First Posted (Actual)
January 16, 2025
Study Record Updates
Last Update Posted (Actual)
May 6, 2026
Last Update Submitted That Met QC Criteria
April 30, 2026
Last Verified
April 1, 2026
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 1R01MH135480-01A1-202407113
- 1R01MH135480-01A1 (U.S. NIH Grant/Contract)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
YES
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Puberty
-
Kayseri City HospitalCompletedPuberty | Puberty Disorders | Central Precocious Puberty (CPP) | Hypothalamic-Pituitary-Ovarian Axis Dysfunction (Disorder)Turkey (Türkiye)
-
IRCCS Azienda Ospedaliero-Universitaria di BolognaCompletedCentral Precocious Puberty (CPP)Italy
-
AbbVieCompletedCentral Precocious Puberty (CPP)United States, Puerto Rico
-
Children's Hospital of Fudan UniversityTerminated
-
Debiopharm International SAActive, not recruitingCentral Precocious PubertyUnited States, Argentina, Brazil, Chile, Mexico
-
Foresee Pharmaceuticals Co., Ltd.QPS Holdings LLC; Changchun GeneScience Pharmaceutical Co., Ltd.Active, not recruitingPuberty; Precocious, CentralUnited States, China, Taiwan, Puerto Rico
-
IpsenCompleted
-
TakedaCompletedCentral Precocious PubertyChina
-
TakedaCompletedCentral Precocious PubertyChina
-
Debiopharm International SACompletedCentral Precocious PubertyUnited States, Chile, Mexico
Clinical Trials on Social Rejection Task
-
University of California, San FranciscoNational Heart, Lung, and Blood Institute (NHLBI)Completed
-
Western Kentucky UniversityCompleted
-
University of California, Los AngelesUCLA Norman Cousins Center for PsychoneuroimmunologyCompleted
-
Clemson UniversityUniversity of VermontCompleted
-
University Hospital, Strasbourg, FranceNot yet recruitingAutism Spectrum Disorder (ASD) | Attention Deficit Disorder With or Without Hyperactivity (ADHD)
-
University Medicine GreifswaldCompleted
-
Tel-Aviv Sourasky Medical CenterCompletedSocial AnxietyIsrael
-
Baylor College of MedicineUniversity of Pittsburgh; Brown UniversityActive, not recruitingObsessive-Compulsive Disorder | OCDUnited States
-
University Hospital, CaenUnknownSchizophrenia | Interpersonal Relations | Magnetic Resonance Imaging, FunctionalFrance
-
University of California, IrvineUniversity of California, Davis; University of California, San FranciscoCompletedStress, Psychological | Pregnancy Related | Glucose Intolerance During PregnancyUnited States